Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-29

FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OXYTROL (oxybutynin) by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYTROL (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL (OXYBUTYNIN)